Actelion To Pay $360M To Settle Federal Drug Co-Pay Kickback Allegations

(December 6, 2018, 2:51 PM EST) -- BOSTON — Actelion Pharmaceuticals US Inc. has agreed to pay $360 million plus interest to resolve federal allegations that it paid kickbacks through a charitable foundation to illegally pay drug co-pays...
To view the full article, register now.